<ul><li>Granules India Limited is acquiring Swiss-based CDMO company Senn Chemicals AG, specializing in peptides.</li><li>The acquisition is expected to close in the first half of 2025, subject to certain conditions.</li><li>The acquisition aligns with Granules' vision to enter the peptide-based anti-diabetic and anti-obesity market.</li><li>Granules aims to become a key player in the development and manufacturing of peptide-based applications across industries.</li></ul>

Granules India enters CDMO business by acquiring Swiss-based Senn Chemicals AG

Discover more